Quanterix Corporation QTRX 深 滬
已收盤 05-15 16:00:00 美东时间
2.75
-0.020
-0.72%
華盛通- 最 高2.895
- 今 開2.75
- 成交量 150.38万股
- 最 低 2.679
- 昨 收 2.77
- 總市值 1.29亿
- 52周最高 8.77
- 市盈率 靜 --
- 換手率 3.20%
- 52周最低 2.56
- 委 比 -61.51%
- 總股本 4706.50万
- 歷史最高 92.57
- 量 比 0.75
- 振 幅 7.80%
- 歷史最低 2.56
- 每 手 1
- 風險率 1.20%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Quanterix Appoints CFO Vandana Sriram Plans To Depart
Quanterix Corporation (NASDAQ:QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that Vandana Sriram, its Chief Financial Officer ("CFO") will
05-13 04:12
美股大行评级 | 绩后暴跌10%，ARM仍获高盛、富国银行等多家大行上调目标价；康宁、优步、飞塔信息、西维斯、Agilon Health等获多家大行上调目标价
今日重点评级关注：Citizens：维持BioCryst制药"跑赢大市"评级，目标价从25美元升至28美元；富国银行：维持曼恩凯德生物医疗"超配"评级，目标价从8美元升至10美元
05-08 12:05
TD Cowen Maintains Hold on Quanterix, Lowers Price Target to $4
TD Cowen analyst Dan Brennan maintains Quanterix (NASDAQ:QTRX) with a Hold and lowers the price target from $7 to $4.
05-08 03:46
Quanterix shares are trading lower after the company reported mixed Q1 financial results.
Quanterix shares are trading lower after the company reported mixed Q1 financia...
05-07 22:57
Earnings Scheduled For May 6, 2026
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
Quanterix Affirms FY2026 Sales Guidance of $169.000M-$174.000M vs $170.887M Est
Quanterix (NASDAQ:QTRX) affirms FY2026 sales outlook from $169.000 million-$174.000 million to $169.000 million-$174.000 million vs $170.887 million estimate.
05-07 04:03
Quanterix Q1 EPS $(0.37) Beats $(0.45) Estimate, Sales $36.415M Miss $37.221M Estimate
Quanterix (NASDAQ:QTRX) reported quarterly losses of $(0.37) per share which beat the analyst consensus estimate of $(0.45) by 17.78 percent. This is a 30.19 percent increase over losses of $(0.53) per share from the
05-07 04:02
Qaunterix Brand, Lucent Diagnostics, Collaborates With Tempus To Integrate Blood-Based Alzheimer's Biomarker Testing Into Clinical Workflows
Agreement supports the identification of patients eligible for Alzheimer's disease biomarker testing through Tempus Next and enables neurologists to order LucentAD® Complete on Tempus' clinical ordering platform
05-06 20:04
美股大行评级 | 大摩上调Lumentum目标价从595美元升至710美元；康宁、道富银行、Ally Financial获多家机构上调目标价
今日重点评级关注：Canaccord Genuity：维持Vertical Aerospace"买入"评级，目标价从9.5美元升至10.5美元；Canaccord Genuity：维持AtaiBeckley Inc."买入"评级，目标价从14美元升至15美元
04-21 11:25
Canaccord Genuity Maintains Hold on Quanterix, Lowers Price Target to $4
Canaccord Genuity analyst Kyle Mikson maintains Quanterix (NASDAQ:QTRX) with a Hold and lowers the price target from $8 to $4.
04-21 00:14
